LWANC
REGN icon

Laurel Wealth Advisors (North Carolina)’s Regeneron Pharmaceuticals REGN Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6
Closed -$4K – 596
2022
Q2 		$4K Hold
6
– – ﹤0.01% 475
2022
Q1 		$4K Hold
6
– – ﹤0.01% 513
2021
Q4 		$4K Hold
6
– – ﹤0.01% 515
2021
Q3 		$4K Hold
6
– – ﹤0.01% 517
2021
Q2 		$3K Hold
6
– – ﹤0.01% 632
2021
Q1 		$3K Sell
6
-15
-71% -$7.3K ﹤0.01% 573
2020
Q4 		$10K Buy
21
+6
+40% +$3.24K ﹤0.01% 417
2020
Q3 		$8K Hold
15
– – ﹤0.01% 400
2020
Q2 		$9K Hold
15
– – ﹤0.01% 387
2020
Q1 		$7K Buy
+15
New +$6.19K ﹤0.01% 391

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return